This is a R&D company. They have a compound collection. They are still spending huge money every year to look for novel candidates and new indications. To do screening work, they need do reference search. They need a priority list for planning and a summary list for decision makers. They have well-known doctors and scientists on the committee. Who cares a poster's list or imagination
What are they doing?, page-24
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
